Operative indications for lung cancer with idiopathic pulmonary fibrosis

被引:40
|
作者
Kushibe, K. [1 ]
Kawaguchi, T. [1 ]
Takahama, M. [1 ]
Kimura, M. [1 ]
Tojo, T. [1 ]
Taniguchi, S. [1 ]
机构
[1] Nara Med Univ, Sch Med, Kashihara, Nara 6348522, Japan
来源
THORACIC AND CARDIOVASCULAR SURGEON | 2007年 / 55卷 / 08期
关键词
idiopathic pulmonary fibrosis; lung cancer; acute respiratory distress syndrome;
D O I
10.1055/s-2007-965645
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: idiopathic pulmonary fibrosis (IPF) is well known to be associated with lung cancer. However, surgical morbidity and mortality in lung cancer patients with IPF remains unclear. Methods: The data of patients who underwent surgery for non-small cell lung cancer were retrospectively reviewed. Results: Of the 1063 patients with lung cancer, 33 (3.1%) had IPF. Patients with IPF had significantly higher postoperative pulmonary morbidity and mortality than those without IPF (33.3 vs. 2.0%; 18.2 vs. 1.3%, respectively, p < 0.0001). Patients with IPF had a significantly higher incidence of postoperative acute lung injury/acute respiratory distress syndrome (ALI/ARDS) than those without IPF (27.3 vs. 1.3%, p < 0.0001). IPF patients with postoperative ALI/ARDS had a significantly lower preoperative %FVC than those without postoperative ALI/ARDS (74 +/- 9 vs. 103 +/- 14%, p < 0.0001). Conclusions: Lung cancer patients with IPF who have a low preoperative %FVC should be carefully assessed prior to any surgical intervention.
引用
收藏
页码:505 / 508
页数:4
相关论文
共 50 条
  • [21] Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
    Ballester, Beatriz
    Milara, Javier
    Cortijo, Julio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03)
  • [22] Evaluation of Perioperative Nintedanib for Lung Cancer with Idiopathic Pulmonary Fibrosis
    Sumiya, R.
    Banno, T.
    Ueno, H.
    Hirayama, S.
    Suzuki, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S421 - S421
  • [23] Primary Lung Cancer in Patient with Idiopathic Pulmonary Fibrosis.
    Kang, H. H.
    Lee, S. H.
    Kim, Y. H.
    Kim, J. W.
    Kim, S. S.
    Kim, M. S.
    Park, C. K.
    Ahn, J. H.
    Kim, C. H.
    Moon, H. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [24] Lung cancer in patients with idiopathic pulmonary fibrosis: CT findings
    Lee, HJ
    Im, JG
    Ahn, JM
    Yeon, KM
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1996, 20 (06) : 979 - 982
  • [25] Genomic profiling of lung cancer associated with idiopathic pulmonary fibrosis
    Noro, Rintaro
    Miyanaga, Akihiko
    Fukuizumi, Aya
    Kunugi, Shinobu
    Sugano, Teppei
    Omori, Miwako
    Minegish, Yuji
    Usuda, Jitsuo
    Seike, Masahiro
    Kubota, Kaoru
    Hirao, Mamiko
    Matsuda, Kuniko
    Gemma, Akihiko
    CANCER RESEARCH, 2019, 79 (13)
  • [26] Challenges in management of lung cancer coexisting with idiopathic pulmonary fibrosis
    Arumugam, Minalosani
    Anthony, Albert Iruthiaraj Lourdesamy
    RESPIROLOGY, 2023, 28 : 407 - 408
  • [27] Genomic profiles of lung cancer associated with idiopathic pulmonary fibrosis
    Hwang, Ji An
    Kim, Deokhoon
    Chun, Sung-Min
    Bae, SooHyun
    Song, Joon Seon
    Kim, Mi Young
    Koo, Hyun Jung
    Song, Jin Woo
    Kim, Woo Sung
    Lee, Jae Cheol
    Kim, Hyeong Ryul
    Choi, Chang-Min
    Jang, Se Jin
    JOURNAL OF PATHOLOGY, 2018, 244 (01): : 25 - 35
  • [28] Application of MSD on the lung cancer associated idiopathic pulmonary fibrosis
    Bao, Wei
    Li, Ying-Ji
    Gu, Jin-Fan
    Yang, Cong-Lin
    Wang, Yi-Da
    Bing, Tie-Jun
    Yu, Wen-Jen
    CANCER RESEARCH, 2024, 84 (06)
  • [29] Idiopathic pulmonary fibrosis and lung cancer: a clinical and pathogenesis update
    Antoniou, Katerina M.
    Tomassetti, Sara
    Tsitoura, Eliza
    Vancheri, Carlo
    CURRENT OPINION IN PULMONARY MEDICINE, 2015, 21 (06) : 626 - 633
  • [30] Advanced Lung Cancer with Idiopathic Pulmonary Fibrosis How to Treat?
    Lichert, Frank
    PNEUMOLOGIE, 2023, 77 (07): : 401 - 401